RASA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.114000E-01
Normal-vs-Stage2
5.763800E-01
Normal-vs-Stage3
2.564400E-01
Normal-vs-Stage4
7.649200E-01
Stage1-vs-Stage2
6.453000E-01
Stage1-vs-Stage3
2.920400E-01
Stage1-vs-Stage4
2.479400E-01
Stage2-vs-Stage3
2.004400E-01
Stage2-vs-Stage4
3.491600E-01
Stage3-vs-Stage4
1.442220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.391400E-01
Normal-vs-AfricanAmerican
6.493000E-01
Normal-vs-Asian
4.161600E-01
Caucasian-vs-AfricanAmerican
2.929800E-01
Caucasian-vs-Asian
1.976830E-01
AfricanAmerican-vs-Asian
9.647700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.341600E-01
Normal-vs-Female
5.588000E-01
Male-vs-Female
6.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.916200E-01
Normal-vs-Age(41-60Yrs)
6.723400E-01
Normal-vs-Age(61-80Yrs)
5.068800E-01
Normal-vs-Age(81-100Yrs)
4.138000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.780800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.483800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.116600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.247530E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.660100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.026000E-01
Normal-vs-Daily Drinker
4.052200E-01
Normal-vs-Weekly Drinker
1.972570E-01
Normal-vs-Occasional Drinker
5.668600E-01
Normal-vs-Social Drinker
5.941400E-01
Non Drinker-vs-Daily Drinker
1.781840E-01
Non Drinker-vs-Weekly Drinker
9.370000E-01
Non Drinker-vs-Occasional Drinker
5.468000E-01
Non Drinker-vs-Social Drinker
5.927700E-02
Daily Drinker-vs-Weekly Drinker
3.406000E-01
Daily Drinker-vs-Occasional Drinker
9.232000E-02
Daily Drinker-vs-Social Drinker
6.816900E-03
Weekly Drinker-vs-Occasional Drinker
6.057600E-01
Weekly Drinker-vs-Social Drinker
1.446970E-01
Occasional Drinker-vs-Social Drinker
2.614200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.864990E-01
Normal-vs-Grade 2
7.976200E-03
Normal-vs-Grade 3
9.040400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.369190E-01
Grade 1-vs-Grade 3
4.463700E-02
Grade 1-vs-Grade 4
1.864990E-01
Grade 2-vs-Grade 3
2.578400E-01
Grade 2-vs-Grade 4
7.976200E-03
Grade 3-vs-Grade 4
9.040400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.166400E-01
Normal-vs-NonDiabetic
5.051200E-01
Diabetic-vs-NonDiabetic
8.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.277400E-01
Normal-vs-NoPancreatitis
5.069200E-01
Pancreatitis-vs-NoPancreatitis
2.902600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.312400E-01
Normal-vs-N1
5.607200E-01
N0-vs-N1
6.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.672400E-01
Normal-vs-TP53-NonMutant
5.030600E-01
TP53-Mutant-vs-TP53-NonMutant
4.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
